BCL2 and cancer: Venetoclax belongs to BCL2 homology 3 (BH3) mimetics that trigger cancer cell apoptosis by displacing proapoptotic BCL2 proteins, including BIM from the anti-apoptotic BCL2 protein (Figure 8).